The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the ...

According to a 2020 study, autoimmune diseases disproportionately affect women – accounting for nearly 80 per cent of cases.

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily characterized by insulin ...

US pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, ...

A study published in the Journal of the International Union of Crystallography found that it provides three times the energy ...

According to a new study published in the journal Biomedicine & Pharmacotherapy, CBD oil may help counteract the negative effects of a high-calorie diet by influencing insulin and glucagon regulation ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

The drug has seen strong demand in the US and Europe, and its India launch is part of Lilly’s broader strategy to expand ...

As research continues, Mounjaro may redefine medical weight loss strategies, but its ethical implications and long-term ...

Discover how to get Mounjaro for weight loss, its benefits, side effects, pricing, and how Mitolyn can enhance your results.

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...

Global pharmaceutical company Eli Lilly and Company (India) has introduced Mounjaro (tirzepatide) in India, a breakthrough drug for the treatment of Type 2 diabetes and obesity. Approved by the ...